S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Canton Fair Debuts Fair2Care Medical Program for Global Buyers

The 140th Canton Fair, opening October 15 in Guangzhou, breaks from tradition by launching the Fair2Care International Medical Experience. This initiative merges on-site exhibitions with off-site clinical visits, allowing global trade attendees to explore China’s premium healthcare sector alongside their standard business negotiations.

Canton Fair Debuts Fair2Care Medical Program for Global Buyers
Photo: Bio & News

Located at West Hall 1F in Area D of the Canton Fair Complex, the dedicated International Medical Services Zone will remain open through October 19. The exhibition focuses on four pillars: Greater Bay Area medical excellence, leading clinical specialties, general healthcare, and the full industry-service-trade chain. Beyond the exhibition floor, organizers have curated three off-site channels that provide direct access to advanced medical care, professional health management, and traditional Chinese medicine wellness practices.

Buyers interested in these services must register via the official portal or scan the QR codes displayed on event posters. The program incentives include on-site physiotherapy sessions and traditional tea tastings, though capacity for the off-site clinical visits is strictly limited. By integrating these health-focused experiences, the Canton Fair aims to position Guangzhou as a primary hub for both industrial trade and high-end international healthcare services.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!